Medirom Healthcare Technologies Inc. MRM
Nasdaq · XNAS · stock · Services-Personal Services · website · IPO 2020-12-29
Medirom Healthcare Technologies Inc. statistics & valuation
Key ratios (by fiscal year)
| Ratio | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Gross margin | 27.1% | 23.0% | 27.4% | — | — |
| Operating margin | -0.2% | -5.7% | 1.4% | -8.7% | -22.3% |
| Net margin | 1.8% | 1.7% | 2.1% | -18.3% | -16.1% |
| FCF margin | -16.9% | -11.2% | -11.6% | -12.1% | -13.2% |
| Return on assets | 1.8% | 1.7% | 2.2% | -17.2% | -9.4% |
| Return on equity | 15.1% | 53.4% | -250.9% | 475.5% | -109.8% |
| Debt / equity | 1.40× | 5.33× | -21.03× | -4.36× | 1.85× |
| Current ratio | 0.65 | 0.49 | 0.65 | 0.43 | 0.79 |
| Revenue growth | 21.5% | -1.8% | 28.5% | 61.9% | -14.5% |
Source: SEC EDGAR filings · CIK 0001819704 · as of 2024-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.